LLY Stock Chart & Fundamental Analysis

Interactive Chart

About Eli Lilly and Company

Name

Eli Lilly and Company

CEO

David A. Ricks

Website

www.lilly.com

Industry

Healthcare

Year Founded

1876

Employees

47,000

Eli Lilly and Company researches, develops, and commercializes human medicines, operating as a large pharmaceutical company listed on the NYSE as LLY. Its portfolio spans diabetes, oncology, immunology, neuroscience, and other specialty therapies, and it recorded $65.2 billion of revenue in FY2025.

Analyst Ratings

Consensus Recommendation

Buy5

Hold2

Sell0

Fundamentals & Financials

Revenue (TTM)

$72.2B

Net Income (TTM)

$25.2B

EPS (TTM)

$28.2

ROA (TTM)

21.68%

Current Ratio

1.5

Dividend Yield

0.19%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$19,799M	$19,292M	$17,600.8M
Cost of Sales	$3,577M	$2,883.7M	$3,008.3M
Gross Profit	$16,222M	$16,408.3M	$14,592.5M
Operating Income	$8,850M	$8,775.3M	$8,386.1M
Net Income	$7,396M	$6,636M	$5,582.5M
EPS	$8.27	$7.41	$6.22

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Eli Lilly and Company's Technical Indicators Summary

LLY is a Strong Buy with clear trend confirmation, strong momentum and heavy volume support. The ADX indicates a robust trend and MACD plus CCI are strongly positive, while the stock trades well above its short-, medium- and 200-day moving averages, showing broad directional conviction. ATR is moderate and consistent with a steady uptrend, and OBV is strongly positive, signaling accumulation. The classic pivot lies below the price, adding a technical support reference. Technical takeaway: Strong Buy.

Buy

5 signals

Neutral

2 signals

Sell

0 signals

Overall: Bullish71% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	67.02	Neutral	RSI (67.02) is neutral.
Stochastic %K (14, 3, 3)	76.42	Neutral	Stochastic (76.42) is neutral.
CCI (20)	134.59	Buy	CCI (134.59) > 100, indicating strong upward momentum.
WPR (14)	-17.32	Sell	Williams %R (-17.32) > -20, indicating overbought.
Momentum (10)	98.50	Buy	Momentum (98.50) is positive.
MFI	54.06	Neutral	MFI (54.06) is neutral.
MACD Level (12, 26)	38.32	Buy	Confirmed uptrend: MACD (38.32) is positive and above its signal line (34.12).
Bollinger Bands	$1067.42 - $1226.29	Neutral	Price is within the bands.
ATR (14)	$39.43 (3.26%)	Neutral	Moderate Volatility (3.26%).
ADX (14)	31.83	Buy	Strong uptrend (ADX > 25) with bullish directional movement. ADX(31.83), +DI(29.57), -DI(14.46)
OBV	86,825,534	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(86,825,534), 20D-SMA-OBV(78,961,157)
Classic Pivot Point	$1194.39	Neutral	Price ($1210.50) is above the pivot ($1194.39) but not yet breaking resistance R1 ($1214.86) — mildly bullish / neutral zone.
Fibonacci Pivot Point	$1194.39	Neutral	Price ($1210.50) is above the pivot ($1194.39) but not yet breaking resistance R1 ($1211.04) — mildly bullish / neutral zone.
Simple Moving Averages	$985.00 - $1159.24(5 indicators)	Buy	SMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$969.04 - $1173.67(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Into the close, LLY still reflected a gentle 1.57% gap from yesterday. The session wrapped with a strong sector advance of 2.65%, creating a supportive backdrop for LLY. LLY moves modestly higher amid a strong sector rally; supportive backdrop from sector gains.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+19.09%

52-Week Position

Near highs

95.5%

Updated: July 2, 2026 at 20:16 UTC